Are Clostridioides difficile infections being overdiagnosed in hematopoietic stem cell transplant recipients?. Issue 4 (8th April 2020) - Ford, Clyde D.
Abstract: Background: Because both diarrhea due to other causes and gastrointestinal colonization with toxigenic Clostridioides difficile are common in HSCT, there is a possibility of false‐positive diagnoses of C difficile infections (CDI). Methods: We estimated the probability of a patient being colonized by toxigenic C difficile by testing non‐diarrheal surveillance stools from 223 HSCT recipients and the probability that a specimen submitted for C difficile testing was not CDI by determining the number of clinical tests that returned negative from this cohort. The number of expected false‐positive CDI was estimated using these probabilities and compared with observed clinical test results. Results: The expected false‐positive and the observed numbers of positive clinical results were similar. The 20 patients diagnosed with CDI were also similar to 142 patients with diarrhea and C difficile ‐negative stools in number of stools on day of testing, associated symptoms, and the recorded number of days to formed stools. C difficile colonization was most commonly detected during the first week and CDI during the second. Retrospective analysis of 837 patients showed that 18 stools were submitted for each diagnosis of CDI. Ribotyping of the surveillance samples showed 17 ribotypes. Conclusions: Although several assumptions could impact the accuracy of our false‐positive CDI estimates, it appears that many HSCT recipients diagnosed with CDI may actually represent colonized status and an alternative cause of diarrhea. Diagnostic stewardship, including limiting CDI diagnoses to patients with positive toxin and restricting stool submissions to patients with more severe symptoms, may decrease the number of false‐positive diagnoses.